Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: AnakInRa for Treatment of Recurrent Idiopathic Pericarditis
Brief Summary: Recent findings suggest that recurrent pericarditis (RP) may be a previously unrecognized autoinflammatory disease. The pivotal pathogenic role of interleukin (IL)-1 in RP has been shown by the achievement of complete responses after treatment with the recombinant IL-1-receptor antagonist, anakinra. Anakinra is the recombinant form of IL-1Ra. The proposed study is designed to demonstarate the efficacy of anakinra in RP.